Sustained release of spray-dried combination dry powder inhaler formulation for pulmonary delivery

Asian Journal of Pharmaceutical and Clinical Research

Volumn 4, Issue 4, 2011, Pages 112-118

  Shah, Nutan ^a   Kondawar, Manish ^a   Shah, Rohit ^a   Shah, Vishal ^a  

^a Appasaheb Birnale College of Pharmacy   (India)

Author keywords

Fluticasone propionate; HPMC; Leucine; Salmeterol xinafoate; Spray drying

Indexed keywords

ALCOHOL; FLUTICASONE PROPIONATE PLUS SALMETEROL XINAFOATE; HYDROXYPROPYLMETHYLCELLULOSE; LEUCINE;

AQUEOUS SOLUTION; ARTICLE; CONCENTRATION (PARAMETERS); DRUG DELIVERY SYSTEM; DRUG SOLUBILITY; PHYSICAL CHEMISTRY; POWDER INHALER; PULMONARY DELIVERY; SPRAY DRYING; SUSTAINED DRUG RELEASE; SUSTAINED RELEASE FORMULATION; THERMODYNAMICS;

EID: 84859969607     PISSN: 09742441     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Hassan M., Raymond L., Inhalation performance of pollen shape carrier in DPI with different drug mixing ratios: Comparison with lactose carrier, Int. J.f Pharm., 2010, 386, 6-14.
2. M. Kumon, Can low-dose combination products for inhalation be formulated in single crystalline particles? Eur. J. Pharm. Sci., 2010, 40,16-24.
3. Learoyd T, Burrows J, Frenchc E., Seville P, Sustained delivery by Leucine modified chitosan spray-dried respirable powders, Int. J. Pharm., 2009, 372, 97-104.
4. Pilcer G., Amighi K., Formulation strategy and use of excipients in pulmonary drug delivery, Int. J. Pharm., 2010, 392, 1-19.
5. Seville P, Rabbani N., The influence of formulation components on the aerosolization properties of spray-dried powders, J. Controlled Release, 2005; 110, 130-140.
6. Regina westmeier, Combination particles containing Salmeterol xinafoate and Fluticasone propionate: formulation and Aerodynamic assessment, J. pharma. Sci., 2008, 97(6), 2299-2309.
7. R. P. Patel, M. P. Patel and A. M. Suthar, "Spray drying technology: an overview", Indian J. Sci. Tech., 2009, 2(10), 44-47.
8. Matthew D. Jones; The relationship between drug concentration, mixing time, blending order and ternary dry powder inhalation performance, International Journal of Pharmaceutics, 2010, 391, 137-147.
9. Hadinoto K., Zhu K., Drug release study of large hollow nanoparticulate aggregates carrier particles for pulmonary delivery, Int. J. Pharm., 2007, 341, 195-206.
10. Malviya R., Shrivastava P., Formulation, Evaluation and comparison of sustained release matrix tablets of Diclofenac sodium using tamrind gum as release modifier, Asian J. Pharm. Cl. Res., 2010, 3(3), 238-240.
11. Jaspart S, Bertholet P, Piel G, Dogne J, Delattre L, Evrard B, Solid lipid microparticles as a sustained release system for pulmonary drug delivery, Eur. J. Pharm. Biopharm., 2007; 65, 47-56.
12. M. D. Jones; An investigation into the relationship between carrier- based dry powder inhalation performance and formulation cohesive-adhesive force balances, Eur. J. of Pharm. Biopharm., 2008, 69, 496-507.
13. Carr. Classifying flow properties of solids, Chemical Engineering, 1965, 72, 69-72.
14. Pozo-Rodriguez A., Pedraz J.,Short and long term stability study of lyophilized solid lipid nanoparticles for gene therapy, Eur. J. Pharm. Biopharm., 2009, 71(2), 181-189.
15. Ali H., York P., Blagden N., Preparation of hydrocortisone nanosuspension through a bottom-up nanoprecipitation technique using microfluidic reactors, Int. J. Pharm., 2009;375:107-113.
16. Gonnissen Y, Verhoeven E, Peeters E, Remon JP and Vervaet C, "Coprocessing via spray drying as a formulation platform to improve the compactability of various drugs". Eur. J. Pharm. Biopharm., 2008, 69 320-334.
17. Seville P, Learoyd T, Burrows J, French E. Chitosan-based spray-dried respirable powders for sustained delivery of terbutaline sulfate, Eur. J. Pharm. Biopharm., 2008; 68: 224-234.